MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the second quarter and six months ended June 30, 2025. Second Quarter 2025 Highlights* All comparisons are to the quarter ended June 30, 2024, unless otherwise noted Total bookings of $25.6 million compared to $23.3 million Total revenue of $85.7 million compared to $85.6 million Recurring revenue represented 95% of total revenue Financial Health revenue of $54.3
Related Questions
Are there any upcoming product launches, acquisitions, or partnerships that could significantly affect future earnings?
How does the 95% recurring revenue rate compare to industry peers and what does it suggest about revenue stability?
What is the contribution of the Financial Health segment to overall revenue, and is its growth rate sustainable?
How did operating expenses and operating margin change year‑over‑year, and what does that imply for profitability?
What impact could recent macro‑economic factors (e.g., healthcare spending trends) have on the company's outlook?
What does the increase in bookings to $25.6M versus $23.3M indicate about future revenue momentum?
How will the modest revenue growth (from $85.6M to $85.7M) affect investor sentiment and the stock price?
What is the guidance outlook for the remainder of 2025 in terms of bookings, revenue, and EPS guidance?
How does TruBridge’s Q2 performance compare with primary competitors in the healthcare solutions space?
What guidance did TruBridge provide for Q3 and FY 2025, and how does it align with market forecasts?
What is the cash position and debt level after Q2, and are there any covenant or liquidity concerns?
What were the GAAP and non‑GAAP EPS figures for Q2 2025, and how do they compare to expectations?